http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006096518-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48d5f47b1c913165f56d80b98d825122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7601470b029a0359106715aab29fb46a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8329172a4f35c2394d1125fef9ef612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af73d9a90ec5d2851685fa1b30aa0b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93747b59fc99e358c1d0bc3c19dd646d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26f4f57d2275d993f31819a1e42ea077
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-204
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
filingDate 2006-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8a56ad957c01aecfed81c4cc2d9b3f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25bcbf7baac28332dc87818e72d9e161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9aab04ded2587d17cc153c9ce6c1b6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fc240adc66d33d2bd3928df7e396af8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65a76e07e145807c7f572f72cff938c9
publicationDate 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006096518-A3
titleOfInvention Improved gacyclidine formulations
abstract Improved formulations of gacyclidine for direct administration to the inner or middle ear.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8298176-B2
priorityDate 2005-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004022069-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226726635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499455

Total number of triples: 32.